Sagimet Biosciences announces positive topline results from phase 2b trial of denifanstat
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
Collaboration streamlines patient access to oncology clinical trials
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
Subscribe To Our Newsletter & Stay Updated